Yunsong Tong

751 citations

19 papers · 562 indexed · h-index 14

Organic Chemistry top 10%
- Click Chemistry and Applications 2
- Synthesis and biological activity 1
Oncology
- Cancer-related Molecular Pathways 9
Molecular Biology
- Cancer therapeutics and mechanisms 8
- DNA Repair Mechanisms 7
- Chemical Synthesis and Analysis 4
- Receptor Mechanisms and Signaling 2
Toxicology
Computational Theory and Mathematics top 10%
Genetics
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Nan‐Horng Lin Kevin D. Moeller Thomas J. Sowin Saul H. Rosenberg Yvette M. Fobian Norman D. Boyd Hing L. Sham Meiye Wu
Cited by: Organic Chemistry Oncology Molecular Biology
Journals: Blood (1 paper)Journal of Medicinal Chemistry (2 papers)The Journal of Organic Chemistry (1 paper)
Partner nations: United States United Kingdom Poland

In The Last Decade

Yunsong Tong

19 papers receiving 545 citations

Peers

Countries citing papers authored by Yunsong Tong

Since Specialization

Citations

This map shows the geographic impact of Yunsong Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunsong Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunsong Tong more than expected).

Fields of papers citing papers by Yunsong Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunsong Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunsong Tong. The network helps show where Yunsong Tong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yunsong Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yunsong Tong Line = papers co-authored together Yunsong Tong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Abstract A002: Understanding mechanisms of resistance to WRN small molecule inhibitors Molecular Cancer Therapeutics ·Faith Fowler,Aileen Kelly,Cindy Jeffries,Jessica Gajda,Jonathan A. Hickson,Fei Han,Nate Elsen,Mariam George,Danli L. Towne,Xiangdong Xu,Nate Gesmundo,Wei Qiu,Henry Tang,Charlie Hutchins,Yunsong Tong,Mick Dart,Ari J. Firestone	2024	1
2	Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors ACS Medicinal Chemistry Letters ·Yunsong Tong,Alan S. Florjancic,Rick Clark,Chunqiu Lai,Anthony Mastracchio,Gui‐Dong Zhu,Morey L. Smith,Peter Kovar,Bailin Shaw,Daniel H. Albert,Wei Qiu,Kenton L. Longenecker,Xiaoqin Liu,Amanda M. Olson,Donald J. Osterling,Stephen K. Tahir,Darren C. Phillips,Joel Johansson,Andrew J. Souers,Thomas D. Penning	2021	2
3	CDK9 Inhibition Reverses Resistance to ABT-199 (GDC-0199) By Down-Regulating MCL-1 Blood ·Jun Chen,Sha Jin,Paul Tapang,Stephen K. Tahir,Morey L. Smith,John Xue,Haichao Zhang,Wenqing Gao,Yunsong Tong,Richard J. Clark,Justin L. Ricker,Thomas D. Penning,Daniel H. Albert,Darren C. Phillips,Andrew J. Souers,Joel Johansson	2014	1
4	Pyrimidine-Based Tricyclic Molecules as Potent and Orally Efficacious Inhibitors of Wee1 Kinase ACS Medicinal Chemistry Letters ·Yunsong Tong,Maricel Torrent,Alan S. Florjancic,Kenneth D. Bromberg,Fritz G. Buchanan,Debra C. Ferguson,Eric F. Johnson,Loren Lasko,David Maag,Philip J. Merta,Amanda M. Olson,Donald J. Osterling,Nirupama B. Soni,Alexander R. Shoemaker,T.M. Penning	2014	18
5	Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195 ACS Medicinal Chemistry Letters ·Yunsong Tong,Kent D. Stewart,Alan S. Florjancic,John E. Harlan,Philip J. Merta,Magdalena Przytulinska,Nirupama B. Soni,Kerren K. Swinger,Haizhong Zhu,Eric F. Johnson,Alexander R. Shoemaker,Thomas D. Penning	2013	26
6	Aminopyrimidinone Cdc7 Kinase Inhibitors Bioorganic & Medicinal Chemistry Letters ·Keith W. Woods,Chunqiu Lai,Julie M. Miyashiro,Yunsong Tong,Alan S. Florjancic,Edward K. Han,Niru B. Soni,Yan Shi,Loren Lasko,Joel Johansson,Eric F. Johnson,Alexander R. Shoemaker,Thomas D. Penning	2012	18
7	Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents Journal of Medicinal Chemistry ·Yunsong Tong,Jennifer J. Bouska,Peter Ellis,Eric F. Johnson,Joel Johansson,Xuesong Liu,Patrick A. Marcotte,Amanda M. Olson,Donald J. Osterling,Magdalena Przytulinska,Luis E. Rodrı́guez,Yan Shi,Nirupama B. Soni,Jason Stavropoulos,Sheela A. Thomas,Cherrie K. Donawho,David J. Frost,Yan Luo,Vincent L. Giranda,Thomas D. Penning	2009	99
8	Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,Kent D. Stewart,Sheela A. Thomas,Magdalena Przytulinska,Eric F. Johnson,Vered Klinghofer,Joel Johansson,Owen McCall,Niru B. Soni,Yan Luo,Nan‐Horng Lin,Thomas J. Sowin,Vincent L. Giranda,Thomas D. Penning	2008	52
9	Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,Magdalena Przytulinska,Zhi‐Fu Tao,Jennifer J. Bouska,Kent D. Stewart,Chang Park,Gaoquan Li,Akiyo Claiborne,Peter Kovar,Zehan Chen,Philip J. Merta,Mai-Ha Bui,Amanda M. Olson,Donald J. Osterling,Haiying Zhang,Hing L. Sham,Saul H. Rosenberg,Thomas J. Sowin,Nan‐Horng Lin	2007	5
10	Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Gaoquan Li,Zhi‐Fu Tao,Yunsong Tong,Magdalena Przytulinska,Peter Kovar,Philip J. Merta,Zehan Chen,Haiying Zhang,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	2007	9
11	Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao,Gaoquan Li,Yunsong Tong,Zehan Chen,Philip J. Merta,Peter Kovar,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham,Thomas J. Sowin,Nan‐Horng Lin	2007	22
12	Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors Bioorganic & Medicinal Chemistry ·Yunsong Tong,Akiyo Claiborne,Kent D. Stewart,Chang Park,Peter Kovar,Zehan Chen,R.B. Credo,Wen‐Zhen Gu,Stephen L. Gwaltney,Russell A. Judge,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham,Thomas J. Sowin,Nan‐Horng Lin	2007	33
13	Discovery of 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4′-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2′-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao,Gaoquan Li,Yunsong Tong,Kent D. Stewart,Zehan Chen,Mai-Ha Bui,Philip J. Merta,Chang Park,Peter Kovar,Haiying Zhang,Hing L. Sham,Saul H. Rosenberg,Thomas J. Sowin,Nan‐Horng Lin	2007	25
14	Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics International Journal of Cancer ·Zehan Chen,Zhan Xiao,Wen‐Zhen Gu,John Xue,Mai H. Bui,Peter Kovar,Gaoquan Li,Gary Wang,Zhi‐Fu Tao,Yunsong Tong,Nan‐Horng Lin,Hing L. Sham,Jean Y. J. Wang,Thomas J. Sowin,Saul H. Rosenberg,Haiying Zhang	2006	103
15	Design, Synthesis, and Biological Activity of 4-[(4-Cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as Potent and Selective Farnesyltransferase Inhibitors Journal of Medicinal Chemistry ·Le Wang,Gary T. Wang,Xilu Wang,Yunsong Tong,Gerry Sullivan,David Park,Nicholas M. Leonard,Qun Li,Jerry D. Cohen,Wen‐Zhen Gu,Haiying Zhang,Joy Bauch,Clarissa G. Jakob,Charles W. Hutchins,Vincent S. Stoll,Kennan C. Marsh,Saul H. Rosenberg,Hing L. Sham,Nan‐Horng Lin	2004	29
16	Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,Nan‐Horng Lin,Le Wang,Lisa Hasvold,Weibo Wang,Nicholas M. Leonard,Tongmei Li,Qun Li,Jerry D. Cohen,Wen‐Zhen Gu,Haiying Zhang,Vincent S. Stoll,Joy Bauch,Kennan C. Marsh,Saul H. Rosenberg,Hing L. Sham	2003	18
17	Conformationally Constrained Substance P Analogues: The Total Synthesis of a Constrained Peptidomimetic for the Phe⁷-Phe⁸ Region The Journal of Organic Chemistry ·Yunsong Tong,Yvette M. Fobian,Meiye Wu,Norman D. Boyd,Kevin D. Moeller	2000	59
18	Constrained Peptidomimetics for TRH: cis-Peptide Bond Analogs Tetrahedron ·Yunsong Tong,Jacek Olczak,Janusz Zabrocki,Marvin C. Gershengorn,Garland R. Marshall,Kevin D. Moeller	2000	27
19	Conformational probes for elucidating the nature of substance P binding to the NK1 receptor: initial efforts to map the Phe7-Phe8 region Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,Yvette M. Fobian,Meiye Wu,Norman D. Boyd,Kevin D. Moeller	1998	15

About Yunsong Tong

Yunsong Tong is a scholar working on Oncology, Genetics and Molecular Biology, having authored 19 papers that have together received 562 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Cancer therapeutics and mechanisms (8 papers), DNA Repair Mechanisms (7 papers), Chemical Synthesis and Analysis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Click Chemistry and Applications (2 papers), Receptor Mechanisms and Signaling (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Organic Chemistry (270 citations), Oncology (186 citations) and Molecular Biology (345 citations). Yunsong Tong has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Nan‐Horng Lin, Kevin D. Moeller, Thomas J. Sowin, Saul H. Rosenberg, Yvette M. Fobian, Norman D. Boyd, Hing L. Sham, Meiye Wu, Zehan Chen and Peter Kovar. Their work appears in journals such as Blood, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact